- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 727143, 8 pages
Aldose Reductase Inhibitory Activity of Compounds from Zea mays L.
1Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, Republic of Korea
2Institute of Natural Medicine, Hallym University, Chuncheon 200-702, Republic of Korea
3Department of Biochemistry, College of Medicine, Hallym University, Chuncheon 200-702, Republic of Korea
Received 9 November 2012; Revised 11 January 2013; Accepted 11 January 2013
Academic Editor: Elvira Gonzalez De Mejia
Copyright © 2013 Tae Hyeon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. V. Santiago, “Overview of the complications of diabetes,” Clinical Chemistry, vol. 32, no. 10, pp. 48–53, 1986.
- G. Dario, M. Raffaele, Q. Antonio et al., “Tolrestat for mild diabetic neuropathy: a 52-week, randomized, placebo-controlled trial,” Annals of Internal Medicine, vol. 118, no. 1, pp. 7–11, 1993.
- J. Pirart, “Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973,” Diabete et Metabolisme, vol. 3, no. 3, pp. 173–182, 1977.
- Y. N. Chihiro, “Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications,” Pharmacological Reviews, vol. 50, no. 1, pp. 21–33, 1998.
- D. R. Tomlinson, E. J. Stevens, and L. T. Diemel, “Aldose reductase inhibitors and their potential for the treatment of diabetic complications,” Trends in Pharmacological Sciences, vol. 15, no. 8, pp. 293–297, 1994.
- J. H. Kinoshita, “Mechanisms intiating cataract formation,” Investigative Ophthalmology and Visual Science, vol. 13, no. 10, pp. 713–724, 1974.
- T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-β-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003.
- S. D. Varma, I. Mikuni, and J. H. Kinoshita, “Flavonoids as inhibitors of lens aldose reductase,” Science, vol. 188, no. 4194, pp. 1215–1216, 1975.
- S. D. Varma and J. H. Kinoshita, “Inhibition of lens aldose reductase by flavonoids: their possible role in the prevention of diabetic cataracts,” Biochemical Pharmacology, vol. 25, no. 22, pp. 2505–2513, 1976.
- J. Okuda, I. Miwa, and K. Inagaki, “Inhibition of aldose reductases from rat and bovine lenses by flavonoids,” Biochemical Pharmacology, vol. 31, no. 23, pp. 3807–3822, 1982.
- K. K. Adom and R. H. Liu, “Antioxidant activity of grains,” Journal of Agricultural and Food Chemistry, vol. 50, no. 21, pp. 6182–6187, 2002.
- V. Dewanto, X. Wu, and R. H. Liu, “Processed sweet corn has higher antioxidant activity,” Journal of Agricultural and Food Chemistry, vol. 50, no. 17, pp. 4959–4964, 2002.
- M. E. Snook, N. W. Widstrom, B. R. Wiseman, P. F. Byrne, J. S. Harwood, and C. E. Costello, “New C-4”-hydroxy derivatives of maysin and 3'-methoxymaysin isolated from corn silks (Zea mays),” Journal of Agricultural and Food Chemistry, vol. 43, no. 10, pp. 2740–2745, 1995.
- M. Miyazawa and M. Hisama, “Antimutagenic activity of phenyl-propanoids from clove (Syzygium aromaticum),” Journal of Agricultural and Food Chemistry, vol. 51, no. 22, pp. 6413–6422, 2003.
- C. K. Wang and W. H. Lee, “Separation, characteristics, and biological activities of phenolics in areca fruit,” Journal of Agricultural and Food Chemistry, vol. 44, no. 8, pp. 2014–2019, 1996.
- L. R. Fergyson, “Role of plant polyphenols in genomic stability,” Mutation Research, vol. 475, no. 1-2, pp. 89–111, 2001.
- N. Katsube, K. Iwashita, T. Tsushida, K. Yamaki, and M. Kobori, “Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins,” Journal of Agricultural and Food Chemistry, vol. 51, no. 1, pp. 68–75, 2003.
- G. Loo, “Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation,” Journal of Nutritional Biochemistry, vol. 14, no. 2, pp. 64–73, 2003.
- J. H. Renault, P. Thépenier, M. Zèches-Hanrot et al., “Preparative separation of anthocyanins by gradient elution centrifugal partition chromatograghy,” Journal of Chromatography A, vol. 763, no. 1-2, pp. 345–352, 1997.
- S. P. Dufrane, W. J. Malaisse, and A. Sener, “A micromethod for the assay of aldose reductase, its application to pancreatic islets,” Biochemical Medicine, vol. 32, no. 1, pp. 99–105, 1984.
- S. Hayman and J. H. Kinoshita, “Isolation and properties of lens aldose reductase,” The Journal of Biological Chemistry, vol. 240, no. 2, pp. 877–882, 1965.
- Y. S. Lee, Y. H. Kang, J. Y. Jung et al., “Inhibitory constituents of aldose reductase in the fruiting body of Phellinus linteus,” Biological and Pharmaceutical Bulletin, vol. 31, no. 4, pp. 765–768, 2008.
- S. S. Lim, Y. J. Jung, S. K. Hyun, Y. S. Lee, and J. S. Choi, “Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens,” Phytotherapy Research, vol. 20, no. 10, pp. 825–830, 2006.
- S. Sato and P. F. Kador, “Inhibition of aldehyde reductase by aldose reductase inhibitors,” Biochemical Pharmacology, vol. 40, no. 5, pp. 1033–1042, 1990.
- I. Miwa, A. S. Chen, and T. Taguchi, “Glyceraldehyde is present in rat lens and its level is increased in diabetes mellitus,” Ophthalmic Research, vol. 41, no. 2, pp. 98–101, 2009.
- S. Kwang-Hyok, P. Ui-Nam, C. Sarkar, and R. Bhadra, “A sensitive assay of red blood cell sorbitol level by high performance liquid chromatography: potential for diagnostic evaluation of diabetes,” Clinica Chimica Acta, vol. 354, no. 1-2, pp. 41–47, 2005.
- R. Shinolara, Y. Ohta, M. Yamachi, and I. Iahiguro, “Improved fluorometric enzymatic sorbitol assay in human blood,” Clinica Chimica Acta, vol. 273, no. 2, pp. 171–184, 1998.
- R. Yawadio, S. Tanimori, and N. Morita, “Identification of phenolic compounds isolated from pigmented rices and their aldose reductase inhibitory activities,” Food Chemistry, vol. 101, no. 4, pp. 1616–1625, 2007.
- S. Milan, “Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract,” Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69–77, 2011.
- S. de Pascual-Teresa, C. Santos-Buelga, and J. C. Rivas-Gonzalo, “LC-MS analysis of anthocyanins from purple corn cob,” Journal of the Science of Food and Agriculture, vol. 82, no. 9, pp. 1003–1006, 2002.
- M. Hisashi, M. Toshio, T. Iwao, and Y. Masayuki, “Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity,” Chemical and Pharmaceutical Bulletin, vol. 50, no. 6, pp. 788–795, 2002.
- K. M. Bohren and C. E. Grimshaw, “The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition,” Biochemistry, vol. 39, no. 32, pp. 9967–9974, 2000.
- W. G. Robison Jr. and N. Laver, “Ocular lesions in animal models of human diabetes,” in Frontiers in Diabetes Research, Lessons From Animal Diabetes IV, E. Shafrir, Ed., pp. 145–163, Smith-Gordon, London, UK, 1993.